Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05471960

Neuroplasticity in RBD

Neuroplasticity in REM Sleep Behavior Disorder

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
86 (estimated)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
21 Years – 75 Years
Healthy volunteers
Accepted

Summary

REM sleep behavior disorder is a parasomnia that reflects the presence of alpha-synucleinopathy in the brain and is highly predictive of eventual phenoconversion to Parkinson's disease, dementia with Lewy bodies, or multiple system atrophy over the course of years to decades. Neuroplastic adaptations in the brain during the prodromal stage of disease are thought to mask the expression of motor and non-motor signs and may substantially delay diagnosis during a potentially critical time window. This study will examine the state and progression (over 30 to 36 months) of neuroplastic changes in the excitability of the motor and prefrontal cortex (using transcranial magnetic stimulation), the structural and functional connectivity of the brain (using highfield, 7T, magnetic resonance imaging), and the relationship of these changes to the expression of motor and neuropsychological signs, in a cohort of individuals with REM sleep behavior disorder and matched controls.

Conditions

Interventions

TypeNameDescription
OTHERNatural progression over timeEach subject will attend eight testing sessions (MRI scanning, two TMS-motor test visits, two TMS-prefrontal test visits, motor assessments, neuropsychological testing, and overnight sleep testing (polysomnography - PSG).

Timeline

Start date
2022-08-01
Primary completion
2030-08-01
Completion
2030-08-01
First posted
2022-07-25
Last updated
2025-05-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05471960. Inclusion in this directory is not an endorsement.